A large clinical trial has tested whether giving patients whole blood during severe bleeding leads to better outcomes than the standard approach of transfusing individual blood components separately.
The New England Journal of Medicine has published results from the SWiFT trial, which examined a question gaining ground in trauma and emergency medicine: is whole-blood transfusion (giving blood that still contains all its components together, rather than separating them out) actually superior to the current standard of care? The trial’s findings have been summarised by NEJM Editorial Fellow Katerina Lin, MD.
Whole blood has long been used in military medicine, where speed and simplicity matter enormously. But in civilian hospitals, the standard approach has been to transfuse red cells, platelets, and plasma (the liquid part of blood that helps clotting) as separate products, allowing clinicians to adjust each element to a patient’s specific needs. The SWiFT trial set out to test whether reuniting those components into whole blood offers a genuine advantage in outcomes for patients with severe bleeding (known medically as haemorrhage).
The NEJM post does not detail the trial’s headline numbers in the tweet itself, but directs readers to the full published results. Lin’s editorial recap is intended to help clinicians and researchers interpret what the findings mean for practice.
No direct quotes from the trial authors or from Lin appear in the source material beyond the tweet text above.
For Kent residents, severe bleeding emergencies remain a matter for 999. Anyone concerned about a medical situation should contact NHS 111 or speak to their GP.
Key information
- Emergency bleeding: Call 999 immediately
- Non-emergency health concerns: Contact NHS 111 (online or by phone, available 24 hours)
- Full SWiFT trial results: Published in the New England Journal of Medicine; ask your GP or clinician for access
Source: @NEJM